Source-linked trial list

The registrations behind this number.

Verify the exact trial registrations behind a company, intervention, programme or topic count.

Exact trial list

5 matching trial registrations

Intervention Fludarabine
Topic Rapamycin

Showing 1–5 of 5. Every record below meets all the filters shown above.

RecruitingNCT04959175

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

PHASE1 · PHASE2 · 320 planned enrolment

Countries listed: 1
Registry update: October 8, 2026

Verify in the registry →

RecruitingNCT07162038

Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation

PHASE1 · 155 planned enrolment

Countries listed: 1
Registry update: September 21, 2026

Verify in the registry →

RecruitingNCT05327023

Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

PHASE1 · PHASE2 · 430 planned enrolment

Countries listed: 1
Registry update: September 18, 2026

Verify in the registry →

RecruitingNCT05436418

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

PHASE1 · PHASE2 · 260 planned enrolment

Countries listed: 1
Registry update: September 11, 2026

Verify in the registry →

Active Not RecruitingNCT05088356

Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft

PHASE1 · 66 planned enrolment

Countries listed: 1
Registry update: May 12, 2026

Verify in the registry →